Publication Beamlines Strategic Pillar
Cron, Brandi; Macalady, Jennifer L.; Cosmidis, Julie (2021). Organic stabilization of extracellular elemental sulfur in a Sulfurovum-rich biofilm: a new role for EPS?. Patent Number: 10.1101/2021.06.03.446708. Environment
Fraund; Matthew; Bonanno; Daniel J.; China et al. (2020). Optical properties and composition of viscous organic particles found in the Southern Great Plains. Patent Number: 10.5194/acp-2020-255. Environment
Yasaman Yousefi Sigari, Drew Bertwistle, Mark Boland (2021). Vertical Phase Space Measurement Progress at Canadian Light Source. Canada: University of Saskatchewan. 10.18429/JACoW-IPAC2021-MOPAB310. Materials
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
(2021). ANTIBODY. Patent Number: PT3311170T.
(2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0.
(2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T.
(2021). MODELING TEST. Patent Number: PT3311169T.
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.